1. Ministry of Health and Long-Term Care (MOHLTC). Executive Officer Communications—Ontario Public Drug Programs (OPDP) [Internet]. 2019 [cited 2019 Sep 30]. http://health.gov.on.ca/en/pro/programs/drugs/publications/opdpataglance/. Accessed 30 Sept 2019.
2. Naipaul RD, Beca J, Gavura S. 19: Shifting trends: an analysis of IV and take-home cancer drug use and public spending in Ontario. J Popul Ther Clin Pharmacol. 2016;23(Supplement 1):e11.
3. Cancer Care Ontario (CCO). New drug funding program (NDFP) [Internet]. Cancer Care Ont. 2019 [cited 2019 Sep 30]. https://www.cancercareontario.ca/en/Funding/New_Drug_Funding_Program. Accessed 30 Sept 2019.
4. Cancer Care Ontario (CCO). Cancer treatments—drug formulary [Internet]. Cancer Care Ont. 2019 [cited 2019 Sep 30]. https://www.cancercareontario.ca/en/drugformulary/drugs. Accessed 30 Sept 2019.
5. Dangerfield BJ, Morris JS. Top-down or bottom-up: aggregate versus disaggregate extrapolations. Int J Forecast. 1992;8:233–41.